Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9951–10000 of 75496
Garth Hankinson, Judy Schmeling and James Sabia each provided notice to the Company of his or her decision to resign from the Board effective immediately
the Company was notified that, when his current term expires at the Annual Meeting, Mr. Joseph I. Kronsberg will retire from the Board and not stand for re-election as a director
On April 15, 2024, Mr. Jim McCarthy resigned from his position as the Company’s Chief Financial Officer, effective as of such date.
Mr. Lane, Senior Vice President and Interim Chief Financial Officer, and Richard S. Smith, Jr., Senior Vice President, General Counsel, and Secretary, were notified that their employment with the Company will be terminated with an effective date of no later than May 31, 2024, in the case of Mr. Smith, and no later than June 30, 2024, in the case of Mr. Lane, in each case unless an earlier termination date is mutually agreed between each executive officer and the Company.
Mr. Lane, Senior Vice President and Interim Chief Financial Officer, and Richard S. Smith, Jr., Senior Vice President, General Counsel, and Secretary, were notified that their employment with the Company will be terminated with an effective date of no later than May 31, 2024, in the case of Mr. Smith, and no later than June 30, 2024, in the case of Mr. Lane, in each case unless an earlier termination date is mutually agreed between each executive officer and the Company.
George A. Villasana, the Company’s Senior Vice President, Chief Legal Officer and Secretary will retire from those positions effective June 30, 2024.
On April 15, 2024, Edward T. Anderson resigned from the Board of Directors (the “ Board ”) of Lyra Therapeutics, Inc. (the “ Company ”) as well as the Audit Committee and Compensation Committee of the Board.
On April 17, 2024, Thomas Stringer informed the Board of Directors (the "Board") of La Rosa Holdings Corp. (the "Company") of his resignation as a member of the Company's Board effective immediately.
received a notice from Tham Choi Kuen (“Ms. Kuen”), who served as the Chief Financial Officer (the “CFO”) of the Company, of her decision to resign as the CFO of the Company due to health reasons effective immediately.
Ms. Sheng (Dorothy) Liu, the Chief Operating Officer of Green Giant Inc., (the “ Company ”), resigned from her position effective on April 19, 2024.
On April 17, 2024, Caryn Nightengale notified the board of directors (the “Board”) of Nxu, Inc (the ”Company”) of her decision not to stand for reelection to the Board at the expiration of her current term at the Company’s 2024 Annual Metting of Stockholders (the “2024 Annual Meeting”) scheduled for June 14, 2024.
On April 17, 2024, Ms. Stacey Pool informed Noodles & Company ("the Company") that she is resigning from her employment as Chief Marketing Officer with the Company effective May 17, 2024 in order to accept another leadership opportunity within the auto aftermarket sector.
On April 15, 2024, Jim S. Tsai notified Hai Shi, the Chairman of the Board of Directors (the “Board”) and Chief Strategy Officer of Snail, Inc. (the “Snail”), of his decision to resign from his position as the Chief Executive Officer of Snail
On April 15, 2024, Juan Fernandez Pascual tendered to the board of directors of Aimei Health Technology Co., Ltd. (the “ Company ”) his resignation, effective as of that date, as Chief Executive Officer, Secretary and a director of the Company.
On April 18, 2024, Dawn M. Zier, a class I director of Spirit Airlines, Inc. (the "Company"), informed the Company that she will not stand for re-election at the Company's 2024 annual meeting of stockholders (the "Annual Meeting").
On April 18, 2024, Anshul Sadana, the Company’s Chief Operating Officer, notified the Company of his intention to resign from the Company effective May 21, 2024.
to fill the vacant seat created by Melvin Flanigan's resignation on April 8, 2024.
Also, on April 16, 2024, Roy Ben-Dor notified the Board of his intention to retire from the Board effective at the Annual Meeting and to not stand for reelection to the Board.
On April 16, 2024, Clayton E. Woodrum notified the Board of Directors (the “Board”) of Ring Energy, Inc. (the “Company”) of his intention to retire from the Board effective at the 2024 Annual Meeting of Stockholders of the Company (the “Annual Meeting”) and to not stand for reelection to the Board.
On April 15, 2024, Greg Peters informed the Company that he will not stand for re-election as a member of the Board at the Company’s 2024 annual meeting of stockholders (the “ 2024 Annual Meeting ”).
On April 16, 2024, Peter Kight notified indie Semiconductor, Inc. (the “Company”) that he will retire from the Board of Directors of the Company (the “Board”) and will not stand for reelection at the Company's 2024 annual meeting of stockholders.
Mr. Colby Wood notified the board of directors (the "Board") of PROCEPT BioRobotics Corporation (the "Company") that he intends to resign as a member of the Board and as a member of the Audit Committee of the Board, effective at the conclusion of the Board meeting on April 18, 2024.
On April 18, 2024, Kathryn Haun informed Coinbase Global, Inc. (“Coinbase”) that she will not stand for re-election to Coinbase’s Board of Directors (the “Board”) when her current term expires at Coinbase’s 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”).
Mosaic ImmunoEngineering, Inc. (the “Company”) is deeply saddened to announce that director Ms. Gloria Felcyn passed away on April 17, 2024.
On April 18, 2024, Justin B. Wender, a member of the board of directors (the “Board”) of International Money Express, Inc. (the “Company”), informed the Company of his intention to resign from the Board, effective June 21, 2024.
On January 31, 2024, Rhinebeck Bancorp, Inc. (the “Company”), the holding company of Rhinebeck Bank, announced the retirement of Michael J. McDermott, Chief Financial Officer of the Company.
reporting that Johannes Cornelis Maria van Gaalen will cease to serve as Chief Financial Officer concurrently with Michael Beer assuming the position of Chief Financial Officer on April 15, 2024.
Harmonic Inc. (the "Company") announced today that Ian Graham has stepped down from the role of Senior Vice President, Global Sales and will be leaving the Company effective July 5, 2024.
The Company has announced that Timothy P. Newlin, VP – Strategic Business Development’s last day with the Company will be on April 30, 2024.
On April 12, 2024, Sven Strohband notified Rocket Lab USA, Inc. (the “Company”) that he will not stand for re-election to the Company’s board of directors (the “Board”) at the Company’s 2024 Annual Meeting of Stockholders (“2024 Annual Meeting”).
In addition, both Gary L. Libs’ and Reed J. Tanner’s terms as members of the Company’s Board of Directors expired as of the Annual Meeting.
In addition, both Gary L. Libs’ and Reed J. Tanner’s terms as members of the Company’s Board of Directors expired as of the Annual Meeting.
as a result, Vishal Sikri, the current President, Advanced Diagnostics, will no longer hold such role
Tim J. Storms, Managing Director and Chief Risk Officer of the Company and Texas Capital Bank, informed the Company that he plans to retire on or around June 15, 2024.
On April 16, 2024, TLGY Acquisition Corporation (the “Company”), received a notice from Shrijay Vijayan (“Mr. Vijayan”), who served as a director of the Company, of his decision to resign as a member of the Company’s board of directors (the “Board”) and all committees thereof, effective April 16, 2024.
on March 28, 2024, the Company received a notice from Steven Norman (“Mr. Norman”), who served as a director and the Chief Financial Officer (the “CFO”) of the Company, of his decision to resign as the CFO of the Company and as a member of the Board and all committees thereof, effective on March 28, 2024.
On April 16, 2024, Veronica Jordan, Ph.D. notified the Board of Directors of the Company (the “ Board ”) of her decision to resign as a Class I director of the Company and as the Chair of the Compensation Committee of the Board and as a member of the Audit Committee of the Board, effective as of the close of business on April 17, 2024, New York City time.
On the Transition Date, Dr. Dugel succeeded Antony C. Mattessich as the Company’s President and Chief Executive Officer, and Mr. Mattessich resigned from the board of directors of the Company.
Effective upon the commencement of Dr. Waheed’s employment, Rabia Gurses Ozden, M.D., will cease to serve as the company’s Chief Medical Officer.
On April 18, 2024, James Mish, a Director of the Company, provided written notice to the Company that he is resigning effective immediately.
On April 18, 2024, Nora B. Sullivan, a Director of 22 nd Century Group, Inc. (the “Company”), provided written notice to the Company that she is resigning effective immediately.
On April 15, 2024, Robert Kalsow-Ramos and Matthew Nord informed the Board of Directors of TD SYNNEX Corporation (the “Company”) that they will resign from the Company’s Board of Directors, effective as of April 15, 2024.
On April 15, 2024, Robert Kalsow-Ramos and Matthew Nord informed the Board of Directors of TD SYNNEX Corporation (the “Company”) that they will resign from the Company’s Board of Directors, effective as of April 15, 2024.
On April 15, 2024, Sung Lee, Executive Vice President and Chief Financial Officer of Vir Biotechnology, Inc. (the “Company”), informed the Company that he will be stepping down from his role, effective May 3, 2024, to pursue another career opportunity.
On April 12, 2024, Jeffrey P. Gehl informed Veritone, Inc. (the “Company”) of his decision not to stand for re-election as a Class I Director at the Company’s 2024 annual meeting of stockholders, currently scheduled to be held on June 13, 2024 (the “Annual Meeting”).
Mr. Shepherd succeeds John T. Adams, who ceased serving as Senior Executive Vice President and Head of Commercial Real Estate of the Company and the Bank on April 12, 2024.
Mr. Gifford succeeds John J. Pinto, who ceased serving as Senior Executive Vice President and Chief Financial Officer of the Company and the Bank on April 12, 2024.
Effective April 18, 2024, Douglas Williams, Ph.D. resigned from his position as Executive Vice President and President, Research and Development of Sana Biotechnology, Inc. (the “Company”).
Mr. Hay’s resignation is expected to be effective June 30, 2024.
After the recent passing of Peter Gaccione, who served as the Chief Executive Officer of American Shared Hospital Services (the “ Company ”), on April 16, 2024,
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.